{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06084481",
            "orgStudyIdInfo": {
                "id": "M24-427"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-506227-29-00",
                    "type": "OTHER",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "AbbVie",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400",
            "officialTitle": "A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-to-assess-adverse-events-and-change-in-disease-activity-in-adult-participants-with-select-advanced-solid-tumor-indications-receiving-intravenous-iv-abbv"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-10",
            "studyFirstSubmitQcDate": "2023-10-10",
            "studyFirstPostDateStruct": {
                "date": "2023-10-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AbbVie",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is given to adult participants to treat advanced solid tumors.\n\nABBV-400 is an investigational drug being developed for the treatment of advanced solid tumors. Study doctors put the participants in groups called cohorts. Each cohort receives ABBV-400 alone (monotherapy) followed by a safety follow-up period. Approximately 220 adult participants with hepatocellular carcinoma (HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), esophageal squamous cell carcinoma (ESCC), triple negative breast cancer (TNBC), hormone receptor+/human epidermal growth factor receptor 2 negative (HER2-) breast cancer (hormone receptor-positive \\[HR+\\]/HER2-breast cancer \\[BC\\]), head and neck squamous-cell-carcinoma (HNSCC), or advanced solid tumors, will be enrolled in the study in approximately 60 sites worldwide.\n\nIn the each cohorts, participants with the following advanced solid tumor indications: HCC, PDAC, BTC, ESCC, TNBC, HR+/HER2-BC, and HNSCC will receive intravenous (IV) ABBV-400 monotherapy for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.\n\nThere may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at an approved institution (hospital or clinic). The effect of the treatment will be frequently checked by medical assessments, blood tests, questionnaires and side effects."
        },
        "conditionsModule": {
            "conditions": [
                "Hepatocellular Carcinoma",
                "Pancreatic Ductal Adenocarcinoma",
                "Biliary Tract Cancers",
                "Esophageal Squamous Cell Carcinoma",
                "Triple Negative Breast Cancer",
                "Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer",
                "Head and Neck Squamous-Cell Carcinoma"
            ],
            "keywords": [
                "Hepatocellular Carcinoma",
                "Pancreatic Ductal Adenocarcinoma",
                "Biliary Tract Cancers",
                "Esophageal Squamous Cell Carcinoma",
                "Triple Negative Breast Cancer",
                "Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer",
                "Head and Neck Squamous-Cell Carcinoma",
                "Solid Tumors",
                "Advanced Solid Tumors",
                "ABBV-400"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 220,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1: Hepatocellular Carcinoma (HCC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with HCC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 2: Pancreatic Ductal Adenocarcinoma (PDAC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with PDAC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 3: Biliary Tract Cancers (BTC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with BTC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 4: Esophageal Squamous Cell Carcinoma, (ESCC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with ESCC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 5: Triple Negative Breast Cancer (TNBC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with TNBC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 6: Hormone Receptor+/HER2-breast Cancer (HR+/HER2-BC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with HR+/HER2-BC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                },
                {
                    "label": "Cohort 7: Head and Neck Squamous-cell-carcinoma (HNSCC)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with HNSCC will receive ABBV-400 for up to 2 years during and up to the treatment period with an additional safety follow-up period of up to 2 years.",
                    "interventionNames": [
                        "Drug: ABBV-400"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "ABBV-400",
                    "description": "Intravenous (IV) Infusion",
                    "armGroupLabels": [
                        "Cohort 1: Hepatocellular Carcinoma (HCC)",
                        "Cohort 2: Pancreatic Ductal Adenocarcinoma (PDAC)",
                        "Cohort 3: Biliary Tract Cancers (BTC)",
                        "Cohort 4: Esophageal Squamous Cell Carcinoma, (ESCC)",
                        "Cohort 5: Triple Negative Breast Cancer (TNBC)",
                        "Cohort 6: Hormone Receptor+/HER2-breast Cancer (HR+/HER2-BC)",
                        "Cohort 7: Head and Neck Squamous-cell-carcinoma (HNSCC)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Objective Response Rate (ORR)",
                    "description": "ORR defined as percentage of participants with confirmed best overall response of confirmed partial response (PR) or better per investigator review according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.",
                    "timeFrame": "Up to 24 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of Response (DOR) for Participants with Confirmed Complete Response (CR)/PR",
                    "description": "DOR is defined for participants achieving a confirmed PR or better as the time from the initial response of PR (or better) per investigator review according to RECIST 1.1 criteria to disease progression or death of any cause, whichever occurs earlier.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Clinical Benefit Rate",
                    "description": "CBR is defined as the proportion of participants with a best overall response of stable disease at least 5 weeks post first dose, confirmed CR or PR per investigator review according to RECIST, version 1.1",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Progression-free Survival (PFS)",
                    "description": "PFS is defined as time from first study treatment to a documented disease progression according to RECIST, version 1.1, as determined by the investigator, or death due to any cause, whichever occurs earlier.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as time from first study treatment to death due to any cause.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Maximum Observed Concentration (Cmax) of ABBV-400",
                    "description": "Cmax of ABBV-400.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Time to Cmax (Tmax) of ABBV-400",
                    "description": "Tmax of ABBV-400.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Area Under the Plasma Concentration-time Curve (AUC) for Total Antibody Concentration",
                    "description": "AUC for total antibody concentration.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Total Antibody Drug Conjugate (ADC) Concentration",
                    "description": "Total ADC concentration.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Plasma Concentrations of Unconjugated Topoisomerase 1 (Top1) Inhibitor Payload",
                    "description": "Plasma concentrations of unconjugated Top1 inhibitor payload.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Antidrug Antibody (ADA)",
                    "description": "Incidence and concentration of anti-drug antibodies.",
                    "timeFrame": "Up to 24 Months"
                },
                {
                    "measure": "Neutralizing Antidrug Antibody (nADA)",
                    "description": "Incidence and concentration of neutralizing anti-drug antibodies.",
                    "timeFrame": "Up to 24 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Laboratory values meeting the criteria laid out in the protocol.\n* Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1.\n* Documented diagnosis of locally advanced or metastatic hepatocellular carcinoma (HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), squamous cell carcinoma of the esophagus, (ESCC), triple negative breast cancer (TNBC), hormone receptor+/HER2-breast cancer (HR+/HER2-BC), or head and neck squamous-cell-carcinoma (HNSCC) (by World Health Organization \\[WHO\\] criteria). Participant meets the criteria for disease activity laid out in the protocol.\n\nExclusion Criteria:\n\n* Have received anticancer therapy including chemotherapy, radiation therapy, immunotherapy, biologic, or any investigational therapy within 28 days or 5 half-lives of the drug (whichever is shorter) prior to the first dose of ABBV-400. Palliative radiation therapy for bone, skin, or subcutaneous metastases with 10 fractions or less is permitted and not subject to a washout period.\n* Unresolved AEs \\> Grade 1 from prior anticancer therapy except for alopecia.\n* History of interstitial lung disease (ILD) or pneumonitis that required treatment with systemic steroids, nor any evidence of active ILD or pneumonitis, including but not limited to those listed in the protocol.\n* History of clinically significant, intercurrent lung-specific illnesses, including those laid out in the protocol.\n* Untreated brain or meningeal metastases (i.e., participants with history of metastases are eligible provided they do not require ongoing steroid treatment for cerebral edema and have shown clinical and radiographic stability for at least 14 days after definitive therapy). Participants may continue on antiepileptic therapy if required.\n* History of other active malignancy, with the exception of those laid out in the protocol.\n* Any autoimmune, connective tissue or inflammatory disorders with documented or suspicious pulmonary involvement at screening (i.e., rheumatoid arthritis, Sjogren's, sarcoidosis etc.), and prior pneumonectomy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ABBVIE CALL CENTER",
                    "role": "CONTACT",
                    "phone": "844-663-3742",
                    "email": "abbvieclinicaltrials@abbvie.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "ABBVIE INC.",
                    "affiliation": "AbbVie",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope National Medical Center /ID# 258645",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "University of Colorado Cancer Center - Cancer Clinical Trials Office /ID# 255128",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045-7158",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Sarah Cannon Research Institute at HealthONE - Denver /ID# 258926",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "Florida Cancer Specialists /ID# 261569",
                    "status": "RECRUITING",
                    "city": "Sarasota",
                    "state": "Florida",
                    "zip": "34232",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.33643,
                        "lon": -82.53065
                    }
                },
                {
                    "facility": "Northwestern University Feinberg School of Medicine /ID# 257378",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611-2927",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "START Midwest /ID# 256581",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546-7062",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Washington University-School of Medicine /ID# 257379",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255132",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065-6007",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke Cancer Center /ID# 255129",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Univ Hosp Cleveland /ID# 257706",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Lifespan Cancer Institute at Rhode Island Hospital /ID# 257693",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "02903-4923",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                },
                {
                    "facility": "MUSC Hollings Cancer Center /ID# 257935",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "Prisma Health /ID# 257697",
                    "status": "RECRUITING",
                    "city": "Greenville",
                    "state": "South Carolina",
                    "zip": "29605",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.85262,
                        "lon": -82.39401
                    }
                },
                {
                    "facility": "Tennessee Oncology-Nashville Centennial /ID# 261568",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203-1632",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center /ID# 255131",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Univ Texas HSC San Antonio /ID# 257708",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229-3901",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics /ID# 260404",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Rambam Health Care Campus /ID# 256649",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "state": "H_efa",
                    "zip": "3109601",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "The Chaim Sheba Medical Center /ID# 255731",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "state": "Tel-Aviv",
                    "zip": "5265601",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center /ID# 258931",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "state": "Tel-Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Rabin Medical Center /ID# 256650",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "4941492",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah Medical Center-Hebrew University /ID# 256655",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "91120",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "NHO Nagoya Medical Center /ID# 261001",
                    "status": "RECRUITING",
                    "city": "Nagoya-shi",
                    "state": "Aichi",
                    "zip": "460-0001",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.18147,
                        "lon": 136.90641
                    }
                },
                {
                    "facility": "Aichi Cancer Center Hospital /ID# 256679",
                    "status": "RECRUITING",
                    "city": "Nagoya-shi",
                    "state": "Aichi",
                    "zip": "464-8681",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.18147,
                        "lon": 136.90641
                    }
                },
                {
                    "facility": "National Cancer Center Hospital East /ID# 258934",
                    "status": "RECRUITING",
                    "city": "Kashiwa-shi",
                    "state": "Chiba",
                    "zip": "277-8577",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.86224,
                        "lon": 139.97732
                    }
                },
                {
                    "facility": "Kyoto University Hospital /ID# 256680",
                    "status": "RECRUITING",
                    "city": "Kyoto-shi",
                    "state": "Kyoto",
                    "zip": "606-8507",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.02107,
                        "lon": 135.75385
                    }
                },
                {
                    "facility": "Shizuoka Cancer Center /ID# 257789",
                    "status": "RECRUITING",
                    "city": "Sunto-gun",
                    "state": "Shizuoka",
                    "zip": "411-8777",
                    "country": "Japan"
                },
                {
                    "facility": "National Cancer Center Hospital /ID# 261136",
                    "status": "RECRUITING",
                    "city": "Chuo-ku",
                    "state": "Tokyo",
                    "zip": "104-0045",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.57779,
                        "lon": 139.71685
                    }
                },
                {
                    "facility": "The Cancer Institute Hospital Of JFCR /ID# 257788",
                    "status": "RECRUITING",
                    "city": "Koto-ku",
                    "state": "Tokyo",
                    "zip": "135-8550",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.66667,
                        "lon": 139.81718
                    }
                },
                {
                    "facility": "Inje University Haeundae Paik Hospital /ID# 260118",
                    "status": "RECRUITING",
                    "city": "Busan",
                    "state": "Busan Gwang Yeogsi",
                    "zip": "48108",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.10278,
                        "lon": 129.04028
                    }
                },
                {
                    "facility": "Gyeongsang National University Hospital /ID# 260408",
                    "status": "RECRUITING",
                    "city": "Jinju",
                    "state": "Gyeongsangnamdo",
                    "zip": "52727",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 35.19278,
                        "lon": 128.08472
                    }
                },
                {
                    "facility": "Seoul National University Hospital /ID# 255730",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul Teugbyeolsi",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Korea University Guro Hospital /ID# 256700",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "state": "Seoul Teugbyeolsi",
                    "zip": "08308",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Pan American Center for Oncology Trials /ID# 262903",
                    "status": "RECRUITING",
                    "city": "Rio Piedras",
                    "zip": "00935",
                    "country": "Puerto Rico",
                    "geoPoint": {
                        "lat": 18.39745,
                        "lon": -66.04989
                    }
                },
                {
                    "facility": "National Taiwan University Hospital /ID# 256713",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "state": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "China Medical University Hospital /ID# 256712",
                    "status": "RECRUITING",
                    "city": "Taichung",
                    "zip": "40447",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.1469,
                        "lon": 120.6839
                    }
                },
                {
                    "facility": "Linkou Chang Gung Memorial Hospital /ID# 259420",
                    "status": "RECRUITING",
                    "city": "Taoyuan City",
                    "zip": "333",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "https://www.abbvieclinicaltrials.com/study/?id=M24-427"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000006528",
                    "term": "Carcinoma, Hepatocellular"
                },
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                },
                {
                    "id": "D000077277",
                    "term": "Esophageal Squamous Cell Carcinoma"
                },
                {
                    "id": "D000001661",
                    "term": "Biliary Tract Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000008113",
                    "term": "Liver Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000001660",
                    "term": "Biliary Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "asFound": "Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9613",
                    "name": "Carcinoma, Hepatocellular",
                    "asFound": "Hepatocellular Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1733",
                    "name": "Esophageal Squamous Cell Carcinoma",
                    "asFound": "Esophageal Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Head and Neck Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4947",
                    "name": "Biliary Tract Neoplasms",
                    "asFound": "Biliary Tract Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11113",
                    "name": "Liver Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4946",
                    "name": "Biliary Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T761",
                    "name": "Biliary Tract Cancer",
                    "asFound": "Biliary Tract Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M11900",
                    "name": "Mitogens",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}